Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Cell Mol Neurobiol
2000 Oct 01;205:569-77. doi: 10.1023/a:1007011911611.
Show Gene links
Show Anatomy links
Forskolin modulates acetylcholine receptor gating by interacting with the small extracellular loop between the M2 and M3 transmembrane domains.
Chen Z
,
White MM
.
???displayArticle.abstract???
1. Forskolin acts as an allosteric modulator of muscle-type nicotinic acetylcholine receptors. Receptors from mouse muscle and Torpedo electroplax demonstrate differential sensitivity to inhibition by forskolin. Previous work from this laboratory suggested that the gamma subunit is responsible for this differential sensitivity. 2. We have used a series of mouse/Torpedo species-chimeric gamma subunits to further define the site of forskolin interaction with the gamma subunit. Analysis of the patterns of forskolin inhibition of receptors containing mouse/Torpedo chimeric gamma subunits along with the mouse alpha, beta, and delta subunits suggests that forskolin interacts with the small extracellular domain that links the M2 and M3 transmembrane domains (the M2-M3 linker). 3. We suggest that the M2-M3 linker domain plays an important role in the transduction of ligand binding to the conformational changes that result in channel opening.
Abramson,
An analog of lophotoxin reacts covalently with Tyr190 in the alpha-subunit of the nicotinic acetylcholine receptor.
1989, Pubmed
Abramson,
An analog of lophotoxin reacts covalently with Tyr190 in the alpha-subunit of the nicotinic acetylcholine receptor.
1989,
Pubmed
Adams,
Voltage jump analysis of procaine action at frog end-plate.
1977,
Pubmed
Aylwin,
Forskolin acts as a noncompetitive inhibitor of nicotinic acetylcholine receptors.
1992,
Pubmed
,
Xenbase
Buller,
Control of Torpedo acetylcholine receptor biosynthesis in Xenopus oocytes.
1988,
Pubmed
,
Xenbase
Campos-Caro,
A single residue in the M2-M3 loop is a major determinant of coupling between binding and gating in neuronal nicotinic receptors.
1996,
Pubmed
,
Xenbase
Changeux,
Effects of chlorpromazine and phencyclidine on mouse C2 acetylcholine receptor kinetics.
1986,
Pubmed
Charnet,
An open-channel blocker interacts with adjacent turns of alpha-helices in the nicotinic acetylcholine receptor.
1990,
Pubmed
Chiara,
Identification of amino acids contributing to high and low affinity d-tubocurarine sites in the Torpedo nicotinic acetylcholine receptor.
1997,
Pubmed
Devillers-Thiéry,
Functional architecture of the nicotinic acetylcholine receptor: a prototype of ligand-gated ion channels.
1993,
Pubmed
DiPaola,
Mapping the alpha-subunit site photolabeled by the noncompetitive inhibitor [3H]quinacrine azide in the active state of the nicotinic acetylcholine receptor.
1990,
Pubmed
Filatov,
The role of conserved leucines in the M2 domain of the acetylcholine receptor in channel gating.
1995,
Pubmed
,
Xenbase
Filatov,
Selective enhancement of the interaction of curare with the nicotinic acetylcholine receptor.
1993,
Pubmed
Galzi,
The multiple phenotypes of allosteric receptor mutants.
1996,
Pubmed
Hucho,
The emerging three-dimensional structure of a receptor. The nicotinic acetylcholine receptor.
1996,
Pubmed
Kao,
Identification of the alpha subunit half-cystine specifically labeled by an affinity reagent for the acetylcholine receptor binding site.
1984,
Pubmed
Karlin,
Toward a structural basis for the function of nicotinic acetylcholine receptors and their cousins.
1995,
Pubmed
Kusama,
Mutagenesis of the GABA rho 1 receptor alters agonist affinity and channel gating.
1994,
Pubmed
,
Xenbase
Labarca,
Channel gating governed symmetrically by conserved leucine residues in the M2 domain of nicotinic receptors.
1995,
Pubmed
,
Xenbase
Laurenza,
Stimulation of adenylate cyclase by water-soluble analogues of forskolin.
1987,
Pubmed
Leonard,
Evidence that the M2 membrane-spanning region lines the ion channel pore of the nicotinic receptor.
1988,
Pubmed
,
Xenbase
Lynch,
Mutations affecting the glycine receptor agonist transduction mechanism convert the competitive antagonist, picrotoxin, into an allosteric potentiator.
1995,
Pubmed
Lynch,
Identification of intracellular and extracellular domains mediating signal transduction in the inhibitory glycine receptor chloride channel.
1997,
Pubmed
McHugh,
Direct anesthetic-like effects of forskolin on the nicotinic acetylcholine receptors of PC12 cells.
1986,
Pubmed
Neher,
Local anaesthetics transiently block currents through single acetylcholine-receptor channels.
1978,
Pubmed
Papke,
Mechanisms of noncompetitive inhibition of acetylcholine-induced single-channel currents.
1989,
Pubmed
Pedersen,
d-Tubocurarine binding sites are located at alpha-gamma and alpha-delta subunit interfaces of the nicotinic acetylcholine receptor.
1990,
Pubmed
Rajendra,
Startle disease mutations reduce the agonist sensitivity of the human inhibitory glycine receptor.
1994,
Pubmed
Revah,
The noncompetitive blocker [3H]chlorpromazine labels three amino acids of the acetylcholine receptor gamma subunit: implications for the alpha-helical organization of regions MII and for the structure of the ion channel.
1990,
Pubmed
Rovira,
A residue in the middle of the M2-M3 loop of the beta4 subunit specifically affects gating of neuronal nicotinic receptors.
1998,
Pubmed
,
Xenbase
Seamon,
Forskolin: unique diterpene activator of adenylate cyclase in membranes and in intact cells.
1981,
Pubmed
Sine,
Local anesthetics and histrionicotoxin are allosteric inhibitors of the acetylcholine receptor. Studies of clonal muscle cells.
1982,
Pubmed
Wagoner,
Modulation of acetylcholine receptor desensitization by forskolin is independent of cAMP.
1988,
Pubmed
White,
Forskolin alters acetylcholine receptor gating by a mechanism independent of adenylate cyclase activation.
1988,
Pubmed
,
Xenbase
White,
Agonist-induced changes in the structure of the acetylcholine receptor M2 regions revealed by photoincorporation of an uncharged nicotinic noncompetitive antagonist.
1992,
Pubmed
Wood,
Short chain and long chain alkanols have different sites of action on nicotinic acetylcholine receptor channels from Torpedo.
1991,
Pubmed
